|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 199 Water Street, 22nd Floor |
Address2 |
|
| City | NEW YORK |
State | NY |
Zip Code | 10038 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 45083-12
|
||||||||
|
6. House ID# 342610000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Corinne Sullivan |
Date | 7/20/2026 6:03:39 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Support for reproductive rights in the following legislation and government actions:
H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families
H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act
H.R. 12 / S. 2150, Womens Health Protection Act (WHPA)
H.R. 2029 / S. 951, Stop Comstock Act
H.R. 5202 / S. 1598, BABIES Act
H.R. 6394 / S. 1599, Midwives for MOMS Act of 2025
H.R. 8074 / S. 4195, Kira Johnson Act
H.R. 8089 / S. 4186, Perinatal Workforce Act
H.R. 8582 / S. 4436, Protecting Human Rights and Public Health in Foreign Assistance Act
H.R. 8807 / S. 4550, Maternal Health Pandemic Response Act
H.R. 9470 / S. 4920, SAFER Health Act of 2026
H.R. 4876, Reproductive Freedom for Veterans Act
H.R. 9441, SAFE Training for OB-GYNs Act
H.R. 211, Equal Access to Contraception for Veterans Act
Offered as an amendment to H.R. 8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
S. 3799, Healthy Start Reauthorization Act of 2026
S. 4574, MARCH for Military Servicemembers Act
H.J.Res. 144 / S.J.Res. 103, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services".
Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone
Providing feedback about provisions impacting reproductive rights in the following legislation:
H.R. 7973, Momnibus Act
H.Res. 1277, Resolution on Human Rights
H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care.
Opposing provisions impacting reproductive rights in the following legislation:
H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities.
Advocacy regarding the impact of Section 71113 and urging Congress not to reinstate or extend the one-year Medicaid funding restriction affecting Planned Parenthood and Maine Family Planning
H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
Opposing all provisions in the following legislation or administrative actions:
Department of Veteran Affairs, VA 38 CFR Part 17 RIN 2900-AS31
H.R. 589, FACE Act Repeal Act of 2025
S. 4873, Promoting Human Flourishing in Foreign Assistance Act
"Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Vandana |
Ranjan |
|
|
|
Sara |
Outterson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |